nitroglycerin and candesartan

nitroglycerin has been researched along with candesartan in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Higaki, J; Mikami, H; Moriguchi, A; Ogihara, T; Zhu, DN1
Kuji, N; Masumori-Maemoto, S; Sugimoto, K; Ueda, S; Umemura, S; Wada, A1
Hirai, N; Kajiwara, I; Kawano, H; Miyamoto, S; Nakamura, H; Ogawa, H; Sakamoto, T; Shimomura, H; Soejima, H; Yasue, H; Yodoi, J; Yoshimura, M1
Goto, M; Hasebe, N; Takahashi, F; Wada, Y1

Reviews

1 review(s) available for nitroglycerin and candesartan

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for nitroglycerin and candesartan

ArticleYear
Attenuation of nitrate tolerance and oxidative stress by an angiotensin II receptor blocker in patients with coronary spastic angina.
    Circulation, 2003, Sep-23, Volume: 108, Issue:12

    Topics: Administration, Cutaneous; Aged; Angina Pectoris; Angiotensin Receptor Antagonists; Benzimidazoles; Biomarkers; Biphenyl Compounds; Brachial Artery; Coronary Vasospasm; Dose-Response Relationship, Drug; Drug Tolerance; Female; Headache; Hemodynamics; Humans; Male; Middle Aged; Nitrates; Nitroglycerin; Oxidative Stress; Receptor, Angiotensin, Type 1; Tetrazoles; Thioredoxins; Treatment Outcome; Ultrasonography; Vascular Patency

2003

Other Studies

3 other study(ies) available for nitroglycerin and candesartan

ArticleYear
Central amino acids mediate cardiovascular response to angiotensin II in the rat.
    Brain research bulletin, 1998, Volume: 45, Issue:2

    Topics: Adrenergic alpha-Agonists; Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Brain Chemistry; Heart Rate; Hemodynamics; Injections, Intraventricular; Male; Microdialysis; Microinjections; Neurotransmitter Agents; Nitroglycerin; Phenylephrine; Rats; Rats, Inbred SHR; Tetrazoles; Vasodilator Agents

1998
Angiotensin II attenuates the vasodilating effect of a nitric oxide donor, glyceryl trinitrate: roles of superoxide and angiotensin II type 1 receptors.
    Clinical pharmacology and therapeutics, 2002, Volume: 71, Issue:6

    Topics: Adult; Angiotensin Receptor Antagonists; Angiotensins; Antihypertensive Agents; Antioxidants; Ascorbic Acid; Benzimidazoles; Biphenyl Compounds; Humans; Infusions, Intra-Arterial; Male; Nitric Oxide Donors; Nitroglycerin; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Reference Values; Research Design; Superoxides; Tetrazoles; Vasoconstriction; Vasodilator Agents

2002
Successful Treatment with an Antihypertensive Drug Regimen Including Eplerenone in a Patient with Malignant Phase Hypertension with Renal Failure.
    Internal medicine (Tokyo, Japan), 2015, Volume: 54, Issue:19

    Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Calcium Channel Blockers; Creatinine; Drug Therapy, Combination; Eplerenone; Heart Failure; Humans; Hypertension, Malignant; Male; Nifedipine; Nitroglycerin; Obesity; Renal Insufficiency; Spironolactone; Tetrazoles; Treatment Outcome; Vasodilator Agents

2015